Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Bladder Neoplasms: early-phase trial registry
1 of 4 indexed Bladder Neoplasms trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Bladder Neoplasms: 4 US clinical trials tracked, 1 recruiting.
Bladder Neoplasms is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Lahey Clinic, running 2 of these trials.
Enrollment posture brief
Registry condition bladder-neoplasms
OPEN 1 | RECR 25% | LATE 0 | EARLY 1 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Bladder Neoplasms lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Bladder Neoplasms on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Bladder Neoplasms is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
Lahey Clinic
NCT00872495
Molecular Analysis Of Bladder Cancer
Lahey Clinic
NCT00871754
Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer
Bioniche Life Sciences
NCT00406068
Bladder Cancer Patient-Reported Outcomes
Baylor College of Medicine
NCT01090388
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Bladder Neoplasms records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Bladder Neoplasms trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Bladder Neoplasms page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Bladder Neoplasms trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Lahey Clinic sponsors the most Bladder Neoplasms trials on record, review their full trial history before evaluating a specific study. See Lahey Clinic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bladder Neoplasms condition card totals 4 registered trials; most-linked intervention Mycobacterial cell wall-DNA complex; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.